How Human Microbiome Talks To Health and Disease

Download as pdf or txt
Download as pdf or txt
You are on page 1of 7

European Journal of Clinical Microbiology & Infectious Diseases

https://doi.org/10.1007/s10096-018-3263-1

REVIEW

How human microbiome talks to health and disease


Jing Cong 1,2 & Xiaochun Zhang 1,2

Received: 20 March 2018 / Accepted: 12 April 2018


# Springer-Verlag GmbH Germany, part of Springer Nature 2018

Abstract
Microbes are ubiquitous in the human body. They usually live in communities, and each of these communities has a distinct
taxonomical structure. Due to its close relationship with human health and disease, the human microbiome has received great
attention and is probably considered to be the most valuable biomarker in preventing and solving human diseases. In this paper,
we first review the value of the human microbiome. Then, we focus on the role of the human microbiome in influencing human
health and disease. Furthermore, we intensively discuss the relationship between intestinal microbiota and cancer therapy.
Finally, we briefly summarize the significance of the human microbiome based on the development of sequencing and bioin-
formatic techniques.

Keywords Human microbiome . Health and disease . Intestinal microbiota . Cancer therapy . Technique

Introduction [3]. The human microbiome contains an enormous group of


prokaryotes, viruses, and eukaryotes that have close relation-
Based on human evolutionary history, we know that the envi- ships to human health and disease. Different microbial com-
ronment has played a main role in the way that we have munities occupy different habitats of the human body. We rely
evolved. Microbes follow the premise of Beverything is ev- on these microbes to aid in nutrition, combat pathogens, and
erywhere, but the environment selects^ [1]. Certainly, mi- modulate our immune system [4]. Therefore, the human
crobes can colonize both outside and inside the human body. microbiome is valuable in human health and disease.
They have evolved with humans and have established a com- Overall, how does the microbiome influence human health
plex host-microbial relationship. As humans, we provide or trigger disease? Is there a causal relationship between mi-
Broom and board^ for these microbes; in turn, they can me- crobial variation and pathology? Recently, numerous studies
tabolize molecules that we cannot metabolize ourselves. This have been conducted on the human microbial variations that
symbiotic relationship not only influences human health but occur in specific disease states, or temporal microbial changes.
also causes a risk of disease occurrence. For example, the occurrence of psoriasis could be related to an
Recently, many researchers have considered the human increased ratio of Firmicutes to Actinobacteria [5], whereas a
microbiome as an Borgan^ [2]. The human microbiome is reduced ratio of Bacteroidetes to Firmicutes may cause obe-
estimated to include 100 trillion cells in total, which is ten sity [6]. A combination of recent technological advances and
times greater than the number of human cells. The aggregate bioinformatics development has driven a surge of interest in
of microbial genes greatly surpasses the number of genes in the human microbiome (Table 1). The purpose of this review
the human genome by orders of magnitude. Therefore, the is to help us better understand the role of human microbiome
microbiome is referred to as Ba second genome^ in humans in the health and disease.

* Xiaochun Zhang The microbiome in sites of the human body


[email protected]

1
Department of Medical Oncology, The Affiliated Hospital of The composition of the human microbiome varies by anatom-
Qingdao University, Qingdao University, Qingdao 266061, China ical sites. In the following sections, we introduce the
2
Cancer Institute, Qingdao 266061, China microbiome in some sites of the human body.
Eur J Clin Microbiol Infect Dis

Table 1 Examples of human


microbiome research associated Terms Relevant diseases Publications
with some specific diseases
Skin/cutaneous Psoriasis 61
Gut/colon/intestinal Colorectal cancer/inflammatory bowel 3960
disease/obesity/rheumatoid arthritis/liver diseases
Oral/mouth/tongue/tooth/ Oral lichen planus 7
subgingival/supragingival
Lung/airway Asthma/chronic obstructive pulmonary disease/idiopathic 387
pulmonary fibrosis/pneumonia
Other (vaginal/nasal) Bacterial vaginitis/chronic rhinosinusitis 117

Number of results obtained by searching for B(microbiota/microbiome/microflora)^ (<Terms>)^ on PubMed


(retrieved 20 March 2018)

The skin microbiome infection [23]. In addition, prior reports have confirmed that
the most important factor controlling cutaneous microbial
As the largest and most exposed organ of the human body, the composition is the ecological zone, followed by the effects
skin is a unique biological barrier to the external environment of ethnicity and the use of particular soaps and shampoos as
[7, 8]. Various microbes, including bacteria, fungi, and viruses, secondary factors [7, 24, 25].
colonize the skin with different distributions [9–11]. Compared
to other body sites, such as the gastro-intestinal tract, the bio- The intestinal microbiome
mass of microbes from cutaneous sites is relatively low [3];
however, the level of bacterial diversity in the skin probably The human intestine harbors numerous microorganisms, in-
approaches that of the colon [12]. Microbes with different skin cluding commensals, symbionts, and some opportunistic path-
locations in humans have disparate richness, abundance, and ogens. As an internalized Bmicrobial organ,^ the intestinal
alpha diversity; however, there is no significant difference in microbiome has a profound influence on human physiology,
alpha diversity among ethnic groups at each skin site [13]. Skin nutrition, and health [26], such as short-chain fatty acid
sites vary with the local conditions of the skin (dry, moist, and (SCFA) production and vitamin synthesis [27, 28]. A previous
sebaceous) and are mainly affiliated with Corynebacterium, study reported that human intestinal microbes comprise
Propionibacteriu, and Staphylococcus [14]. They are primarily 9,879,896 genes by combining 1267 previously and newly se-
influenced by a wealth of intrinsic (host age, diet, gender, im- quenced samples from three continents [29]. Based on micro-
mune status, genetic predisposition, and so on) and extrinsic bial taxa, gene families, and metabolic pathways, the human
(environmental and behavioral) factors [15]. intestinal microbiome is typical for omnivorous primates [30].
These skin microbes play beneficial or harmful roles in the The composition and diversity of the human intestinal
host [16]. We have learned about many diseases in humans microbiome vary greatly with ethnic background, lifestyle,
that are closely linked with the skin microbiome, such as pso- age, and geography [31–33]. Generally, the intestinal
riasis and atopic dermatitis. Psoriasis is associated with exten- microbiome is dominated by members of the divisions
sive variations in the composition and representation of the Bacteroidetes and Firmicutes [34]. However, the intestinal
skin microbiome. Cho and Blaser found that the increased microbiome probably differs in different periods of life. For
ratio of Firmicutes to Actinobacteria species was often ac- example, the structure of the intestinal microbiome varies great-
companied by the occurrence of psoriasis [17]. Atopic derma- ly from the first to the third trimesters of pregnancy, with an
titis is also a common, chronic inflammatory skin disease. The increase in Proteobacteria and Actinobacteria over time [35].
morbidity of atopic dermatitis is often caused by cutaneous The intestinal microbiome, as a complex microbial ecosys-
microbiota infections. For example, Stapbylococcus aureus is tem, has been associated with (inducing or aggravating) many
extremely prevalent on atopic dermatitis skin and has a direct diseases, such as obesity [36], colorectal cancer [37, 38], in-
correlation with atopic dermatitis clinical severity [18]. flammatory bowel disease [39], rheumatoid arthritis [40], and
Meanwhile, parts of the skin microbiome are also involved liver diseases [41]. It has been reported that the intestinal
in the maintenance of skin homeostasis. Studies have found microbiome could act as an ambient factor in regulating fat
that nonpathogenic bacteria, such as Staphylococcus storage in humans [42]. Enterobacter cloacae, which is an
epidermidis and Propionibacterium acnes [19–21], can inhibit obesity-inducing strain in the human intestine, is known to
Staphylococcus aureus to restore balanced communities and cause bacteremia [43]. Akkermansia muciniphila and
alleviate atopic dermatitis-related skin inflammation [22]. Clostridium coccoides have been reported to be closely linked
S. epidermidis could tune the function of resident skin T lym- to decreasing adiposity [44]. Infection with Streptococcus
phocytes and enhance skin defense mechanisms against bovis is a risky sign for colon tumors [45]. Enterotosigenic
Eur J Clin Microbiol Infect Dis

Bacteroides fragilis and Fusobacterium nucletum have been Unlike the intestinal microbiome, the lung microbiome on-
identified to be closely associated with colorectal cancer tissue ly has a density of 10–100 bacterial cells per 1000 human cells
[46]. Patients with colorectal cancer often have a lower micro- [58]. The lung microbiome has a low microbial concentration,
bial diversity and Clostridia abundance [47]. Rather than a but it is important to host immunity. A study showed that
simple causal relationship, there is probably a complex and healthy adults exposed to higher levels of particulates tended
dynamic relationship between intestinal microbial dysbiosis to have a higher level of potentially pathogenic bacteria in
and inflammatory bowel disease (IBD). IBD patients usually their lungs [59]. An imbalanced microbial ecosystem in the
have dysbiosis with reduced numbers of SCFAs-producing lung may incur the development of respiratory diseases [60],
bacteria, which is a factor in the emergence and severity of such as asthma, chronic obstructive pulmonary disease
IBD [48]. Furthermore, dysregulation of host responses in the (COPD), idiopathic pulmonary fibrosis, and pneumonia.
intestinal lumen could influence distant anatomical sites by Adult asthmatics exhibit changes in their lower respiratory
the activation of host immune responses, which occurs in tract microbiome, typically showing enhanced community di-
rheumatoid arthritis [40]. In addition, the liver is the first organ versity and abundance in the Proteobacteria phylum [61]. The
to be exposed to the metabolic products generated by the lung microbiome of advanced COPD patients has been ob-
intestinal microbiome. Many observations have suggested that served to shift from the Bacteroidetes to Proteobacteria phy-
there are close links between intestinal microbial composition lum [62], potentially including its familiar pathogenic mem-
and liver diseases [49]. bers (e.g., Haemophilus spp., Pseudomonas spp.) and occa-
sionally to Firmicutes phylum [63]. There is a positive rela-
tionship between the relative abundance of specific lung mi-
The oral microbiome
crobial community members Staphylococcus spp. and
Streptococcus spp. and the progression of idiopathic pulmo-
The complexity of the oral microbiome is similar to that of the
nary fibrosis [64]. Most pneumonia cases resulting from a
intestinal microbiome, but it is comprised of different species
single pathogen are characterized by high microbial biomass,
and tends to be dominated by Streptococcus spp. [50]. The oral
low microbial diversity, and host inflammation [65].
microbiome is a valuable asset and plays an important role in
Therefore, quantitative and/or qualitative changes in the lung
oral health and disease [51]. Oral microbial communities vary
microbiome may be closely linked with many pulmonary
from childhood to adulthood [52]. Zheng et al. found that there
diseases.
was higher subgingival microbial diversity in ailing dental im-
plant patients than in healthy implant patients, indicating that
periodontal pathogens could play key roles in the progression
Other microbiomes
from healthy implant status to peri-implant disease [53]. The
researchers also compared microbial taxa in oral lichen planus
Except for the skin microbiome, intestinal microbiome, oral
(OLP) patients and healthy individuals and identified the
microbiome, and lung microbiome, microbiomes in other
dysbiosis in the oral microbial community of OLP patients,
sites of the body have also been explored. For example,
indicating a potential microbial role in the progression of OLP.
the vaginal microbiome not only influences human repro-
Dental caries have a polymicrobial etiology caused by various
ductive physiology, but also is potentially affected by host
oral bacterial consortia. Some differentially abundant taxa, such
physiology during puberty and menopause [66, 67]. A
as Lactobacillus, Cryptobacterium, Atopobium, Ochrobactrum,
healthy vagina contains at least five reproducible commu-
Centipeda, and Mycoplasma, are considered to be potential bio-
nity types, each dominated by a single species of
markers to better diagnose dental caries occurrence.
Lactobacillus or by a mixture of other microbes, including
Gardnerella [68]. The nostril microbiome varies seasonally
The lung microbiome in young children [69] and is also very valuable in human
health and disease [70].
Previously, healthy lungs were assumed to be a sterile environ-
ment. However, extensive sequencing analyses from the lungs
of healthy individuals have identified microbial organisms,
such as those in the phyla Bacteroidetes, Proteobacteria, Intestinal microbiota and cancer therapy
Actinobacteria, and Firmicutes, that drive and reflect immune
function and mucosal inflammation [54, 55]. The lung Intestinal microbiota can modulate host physiological func-
microbiome resembles the microbiome of the mouth more tion, inflammation, and immunity to influence health status
closely than the microbiomes of other body sites [56]. and disease occurrence and/or progression [71]. There is
Meanwhile, mouth-lung microbial similarity may be related to growing awareness regarding the role of the intestinal micro-
circadian rhythms, peaking overnight and waning daytime [57]. biota in cancer therapy (Table 2).
Eur J Clin Microbiol Infect Dis

Table 2 Lists of publications


about intestinal microbiota and Cancer therapy Key intestinal microbiota Publications
cancer therapy 2013–2018

Chemotherapy Faecalibacterium prausnitzii [72], Clostridium cluster 97


XIVa [72], Fusobacterium nucleatum [73]
Immunotherapy Akkermansia muciniphila [74], Ruminococcacea [75], 84
Bifidobacterium longum [76], Enterococcus faecium [76],
Collinsella aerofaciens [76]
Radiotherapy Lactobacillus acidophilus, Bifidobacterium bifidum [77, 78] 18

Number of results obtained by searching for B(microbiota/microbiome/microflora)^ (<Terms>)^ on PubMed


(retrieved 20 March 2018)

Intestinal microbiota and cancer chemotherapy responder patients in response to immunotherapy are differ-
ent; however, these results still show the close relationship
Mucositis, which is one of the most debilitating side effects of between the intestinal microbiota and cancer immunotherapy.
chemotherapy, often results in a higher mortality in cancer
patients [79]. Chemotherapy has a detrimental effect on intes- Intestinal microbiota and cancer radiotherapy
tinal microbial composition, which increases in potentially
pathogenic bacteria and decreases in commensal anaerobes The effects of radiotherapy on the intestinal microbiota have
[80]. Significant reductions in Faecalibacterium prausnitzii not been studied extensively; however, radiation-induced
and Clostridium cluster XIVa have been reported during che- bowel injury is influenced by the intestinal microbiota. It has
motherapy, which were thought to contribute to chemotherapy- been reported first that the intestinal microbiota is a key mod-
associated intestinal inflammation and mucositis [72]. ifier of radiation-induced intestinal injury, showing marked
However, Fusobacterium nucleatum was demonstrated to pro- resistance to lethal radiation enteritis [82]. Then, probiotic
mote colorectal cancer resistance to chemotherapy [73]. The Lactobacillus was found to exert protective effects in a pre-
broad-spectrum antibiotics vancomycin and colistin can influ- clinical model of radiation-induced intestinal epithelium inju-
ence the intestinal microbiota, so the efficacy of chemotherapy ry in a TLR-2/cyclo-oxygenase-2-dependent manner [83].
is closely associated with the intestinal microbiota [81]. In There are many studies about ameliorating radiation-induced
addition, antibiotics combined with chemotherapy may work diarrhea using Lactobacillus acidophilus, Bifidobacterium
synergistically to increase bacterial translocation from the gut. bifidum, and other probiotics [77, 78]. Radiotherapy for gyne-
Therefore, an intact intestinal microbiota appears to be required cological cancer patients could result in a decrease in the
for optimal efficacy in cancer chemotherapy. abundance and diversity of intestinal microbiota [84]. In ad-
dition, radiotherapy-induced intestinal injuries promote the
Intestinal microbiota and cancer immunotherapy intestinal microbiota to partly activate the immune reaction,
which is closely correlated with treatment efficacy.
The studies of Gopalakrishnan V et al., Routy B et al., and Therefore, targeting intestinal microbiota with strategies
Matson V et al. have reported that the composition of the such as nutrition, probiotics and prebiotics, or antibiotic selec-
intestinal microbiota could modulate the tumor response to tion may be an effective way to conduct precision medicine in
immunotherapy with blocking antibodies against PD-1 or cancer patients.
PD-L1 in patients with melanoma cancer [74–76]. There is a
significant association between commensal microbial compo-
sition and the clinical response to immune checkpoint inhibi- Microbial sequencing and analytical
tors. Akkermansia muciniphila, which belongs to the technique
Verrucomicrobiaceae family, is more abundant in responder
patients in response to immunotherapy than in non-responders Although microbes are responsible for key functions in the
[74]. Significantly higher alpha diversity and relative abun- determination of human health and disease, high microbial
dance of Ruminococcaceae species are found to be in re- diversity has made it difficult to explore specific functions,
sponder patients with melanoma in response to anti-PD-1 im- especially in the complex human system. Fortunately, techno-
munotherapy [75], whereas Bifidobacterium longum, logical and analytical advances have greatly facilitated studies
Enterococcus faecium, and Collinsella aureofaciens seem to on the composition and function of complex microbes in
be key in another study on responder patients with melanoma humans [85]. DNA sequencing technology developments have
[76]. Due to distinct organ sites, metagenomics technologies, made many discoveries related to the identities and potential
statistical methods, and others, the dominant species of functions of microbes in our own bodies. Previously,
Eur J Clin Microbiol Infect Dis

sequencing was performed on only a single bacterial genome 4. Dethlefsen L, Mcfallngai M, Relman DA (2007) An ecological and
evolutionary perspective on human-microbe mutualism and dis-
using the Sanger approach, which took years to complete. With
ease. Nature 449(7164):811–818
developments in the speed and throughput of nucleic acid se- 5. Zhu GZ, Li JT (2008) Substantial alterations of the cutaneous bac-
quencing technologies, complete bacterial genome sequencing terial biota in psoriatic lesions. PLoS One 3(7):550–550
can be completed in a short time. Next-generation sequencing 6. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER,
of community DNA has made it possible to determine the Gordon JI (2006) An obesity-associated gut microbiome with in-
creased capacity for energy harvest. Nature 444 (7122):1027–1031
specific microbial groups in the human body. Both 16S 7. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight
rRNA sequencing and whole-genome sequencing are com- R (2011) Bacterial community variation in human body habitats
monly used to explore the taxonomical structure and functional across space and time. Science 326(5960):1694–1697
profile of microbial communities. Metatranscriptomics, 8. Wei L, Lei H, Yu P, Ma C, Wu X, Xu J (2014) Nested PCR-
denaturing gradient gel electrophoresis analysis of human skin mi-
metaproteomics, and metabolomics have also offered a wealth
crobial diversity with age. Microbiol Res 169(9–10):686–692
of knowledge about the human microbiome. In addition, the 9. Wylie KM, Mihindukulasuriya KA, Zhou Y, Sodergren E, Storch
extraordinarily large datasets of human microbiome studies GA, Weinstock GM (2014) Metagenomic analysis of double-
show that bioinformatics approaches are indispensable for stranded DNA viruses in healthy adults. BMC Biol 12(1):1–10
analyses. With applications ranging from dissecting microbial 10. Clavaud C, Jourdain R, Barhen A, Tichit M, Bouchier C, Pouradier
F, Rawadi CE, Guillot J, Ménardszczebara F, Breton L (2013)
structures by tracking microbial states, functions, and intercel- Dandruff is associated with disequilibrium in the proportion of the
lular interactions to probing individual cells, analytical major bacterial and fungal populations colonizing the scalp. PLoS
methods will continue to be a key driving force in human One 8(3):e58203
microbiome science. 11. Keisha F, Julia O, Joy Y, Sean C, Clayton D, Meyer JA, Deborah S,
Effie N, Morgan P, Kong HH (2013) Topographic diversity of fun-
gal and bacterial communities in human skin. Nature 498(7454):
367–370
12. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L,
Conclusions Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of
the human intestinal microbial flora. Science 308(5728):1635–
With improvements in sequencing technology and bioinfor- 1638
13. Perez Perez GI, Gao Z, Jourdain R, Ramirez J, Gany F, Clavaud C,
matic approaches, deciphering the roles of the human Demaude J, Breton L, Blaser MJ (2016) Body site is a more deter-
microbiome is very important for the treatment and care in minant factor than human population diversity in the healthy skin
human health. Importantly, a more complete knowledge of microbiome. PLoS One 11(4):e0151990
the human microbiome will contribute to a better understand- 14. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC,
Bouffard GG, Blakesley RW, Murray PR, Green ED (2009)
ing of how diseases influence microbial functions, enabling Topographical and temporal diversity of the human skin
better predictions of impacts and facilitating improved human microbiome. Science 324(5931):1190–1192
health strategies. 15. EA G, JA S (2011) The skin microbiome. Nat Rev Microbiol 9(4):
244
Funding This study was supported by funding from the project funded 16. Chiller K, Selkin BA, Murakawa GJ (2001) Skin microflora and
by China Postdoctoral Science Foundation (2016M602094), Qingdao bacterial infections of the skin. J Investig Dermatol Symp Proc 6(3):
Application Research Project (2016047), Youth Research Fund Project, 170–174
and Qingdao People’s Livelihood Science and Technology Program (16- 17. Cho I, Blaser MJ (2012) The human microbiome: at the interface of
6-2-3-nsh). health and disease. Nat Rev Genet 13(4):260–270
18. Biedermann T (2006) Dissecting the role of infections in atopic
dermatitis. Acta Dermato Venereologica 86(2):99–109
Compliance with ethical standards 19. Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T,
Mizunoe Y (2010) Staphylococcus epidermidis Esp inhibits
Conflict of interest The authors declare that they have no competing Staphylococcus aureus biofilm formation and nasal colonization.
interests. Nature 465(7296):346–349
20. Lai Y, Di NA, Nakatsuji T, Leichtle A, Yang Y, Cogen AL, Wu ZR,
Hooper LV, Schmidt RR, Von AS (2009) Commensal bacteria reg-
ulate Toll-like receptor 3-dependent inflammation after skin injury.
Nat Med 15(12):1377–1382
References
21. Shu M, Wang Y, Yu J, Kuo S, Coda A, Jiang Y, Gallo RL, Huang
CM (2013) Fermentation of Propionibacterium acnes, a commensal
1. Fontaneto D, Hortal J (2012) Microbial biogeography: is every- bacterium in the human skin microbiome, as skin probiotics against
thing small everywhere? Caister Academic Press, Poole, p 87–98 methicillin-resistant Staphylococcus aureus. PLoS One 8(2):1060–
2. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, 1064
Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of 22. Volz T, Skabytska Y, Guenova E, Chen KM, Frick JS, Kirschning
the human intestinal microbial flora. Science 308(5728):1635– CJ, Kaesler S, Röcken M, Biedermann T (2014) Nonpathogenic
1638 bacteria alleviating atopic dermatitis inflammation induce IL-10-
3. Grice EA, Segre JA (2012) The human microbiome: our second producing dendritic cells and regulatory Tr1 cells. J Investig
genome. Annual Rev Genomics Human Genetics 13(1):151–170 Dermatol 134(1):96–104
Eur J Clin Microbiol Infect Dis

23. Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, environmental factor that regulates fat storage. Proceedings of the
Ryan AF, Nardo AD, Gallo RL (2010) Activation of TLR2 by a National Academy of Sciences of the United States of America 101
small molecule produced by Staphylococcus epidermidis increases (44):15718–15723
antimicrobial defense against bacterial skin infections. J Investig 43. Fei N, Zhao L (2013) An opportunistic pathogen isolated from the
Dermatol 130(9):2211–2221 gut of an obese human causes obesity in germfree mice. Isme J
24. Grice EA, Kong HH, Renaud G, Young AC, Bouffard GG, Multidisciplinary J Microbial Ecology 7(4):880–884
Blakesley RW, Wolfsberg TG, Turner ML, Segre JA (2008) A 44. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels
diversity profile of the human skin microbiota. Genome Res LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM (2013)
18(7):1043–1050 Cross-talk between Akkermansia muciniphila and intestinal epithe-
25. Sanmiguel A, Grice EA (2015) Interactions between host factors lium controls diet-induced obesity. Proc Natl Acad Sci U S A
and the skin microbiome. Cellular Molecular Life Sci Cmls 72(8): 110(22):9066–9071
1499–1515 45. Gupta A, Madani R, Mukhtar H (2010) Streptococcus bovis endo-
26. Clemente J, Ursell L, Parfrey LW, Knight R (2012) The impact of carditis, a silent sign for colonic tumour. Color Dis 12(3):164–171
the gut microbiota on human health: an integrative view. Cell 46. Viljoen KS, Dakshinamurthy A, Goldberg P, Blackburn JM (2015)
148(6):1258–1270 Quantitative profiling of colorectal cancer-associated bacteria re-
27. Flint HJ, Scott KP, Louis P, Duncan SH (2012) The role of the gut veals associations between fusobacterium spp., enterotoxigenic
microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol Bacteroides fragilis (ETBF) and clinicopathological features of co-
9(10):577–589 lorectal cancer. PLoS One 10(3):e0119462
28. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel 47. Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ,
BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE (2006) Hayes RB, Yang L (2013) Human gut microbiome and risk for
Metagenomic analysis of the human distal gut microbiome. Science colorectal cancer. J Natl Cancer Inst 105(24):1907–1911
312(5778):1355–1359 48. Gonçalves P, Araújo JR, Di SJ (2018) A cross-talk between
29. Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, Arumugam M, microbiota-derived short-chain fatty acids and the host mucosal
Kultima JR, Prifti E, Nielsen T (2014) An integrated catalog of immune system regulates intestinal homeostasis and inflammatory
reference genes in the human gut microbiome. Nat Biotechnol bowel disease. Inflamm Bowel Dis 24(3):558
32(8):834–841 49. Fox JG (2010) Gut microbes define liver cancer risk in mice ex-
30. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, posed to chemical and viral transgenic hepatocarcinogens. Gut
Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R 59(1):88–97
(2008) Evolution of mammals and their gut microbes. Science
50. Consortium HMP (2012) Structure, function and diversity of the
320(5883):1647–1651
healthy human microbiome. Nature 486(7402):207–214
31. Consortium THMP (2012) Structure, function and diversity of the
51. Wade WG (2012) The oral microbiome in health and disease.
healthy human microbiome. Nature 486(7402):207–214
Pharmacological Research the Official Journal of the Italian
32. Paola MD, Filippo CD, Cavalieri D, Ramazzotti M, Poullet JB,
Pharmacological Society 69 (1):137–143
Massart S, Collini S, Pieraccini G, Lionetti P (2010) PP90 impact
of diet in shaping gut microbiota revealed by a comparative study in 52. Crielaard W, Zaura E, Schuller AA, Huse SM, Montijn RC, Keijser
children from Europe and rural Africa. Proc Natl Acad Sci U S A BJ (2011) Exploring the oral microbiota of children at various de-
107(33):S445–S446 velopmental stages of their dentition in the relation to their oral
33. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello health. BMC Med Genet 4(1):22
MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin 53. Zheng H, Xu L, Wang Z, Li L, Zhang J, Zhang Q, Chen T, Lin J,
AP (2012) Human gut microbiome viewed across age and geogra- Chen F (2015) Subgingival microbiome in patients with healthy
phy. Nature 486(7402):222–227 and ailing dental implants. Sci Rep 5:10948
34. Mardis ER, Gordon JI, Mahowald MA, Turnbaugh PJ, Ley RE, 54. Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Chen
Magrini V (2006) An obesity-associated gut microbiome with in- H, Berger KI, Goldring RM, Rom WN, Blaser MJ (2013)
creased capacity for energy harvest. Nature 444(7122):1027–1031 Enrichment of lung microbiome with supraglottic taxa is associated
35. Koren O, Goodrich J, Cullender T, Spor A, Laitinen K, Bäckhed with increased pulmonary inflammation. Microbiome 1(1):19
HK, Gonzalez A, Werner J, Angenent L, Knight R (2012) Host 55. Twigg HL, Morris A, Ghedin E, Curtis JL, Huffnagle GB, Crothers
remodeling of the gut microbiome and metabolic changes during K, Campbell TB, Flores SC, Fontenot AP, Beck JM (2013) Use of
pregnancy. Cell 150(3):470–480 bronchoalveolar lavage to assess the respiratory microbiome: signal
36. Mulders RJ, Git KCGD, Schéle E, Dickson SL, Sanz Y, Adan RAH in the noise. Lancet Respiratory Medicine 1(5):354–356
(2018) Microbiota in obesity: interactions with enteroendocrine, 56. Venkataraman A, Bassis CM, Beck JM, Young VB, Curtis JL,
immune and central nervous systems. Obes Rev 19(4) Huffnagle GB, Schmidt TM (2015) Application of a neutral com-
37. Plottel C, Blaser M (2011) Microbiome and malignancy. Cell Host munity model to assess structuring of the human lung microbiome.
Microbe 10(4):324–335 MBio 6(1)
38. Jobin C (2017) Human intestinal microbiota and colorectal cancer: 57. Dickson RP, Erbdownward JR, Freeman CM, Mccloskey L, Beck
moving beyond associative studies. Gastroenterology 153(6): JM, Huffnagle GB, Curtis JL (2015) Spatial variation in the healthy
1475–1478 human lung microbiome and the adapted island model of lung
39. Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T- biogeography. Annals Am Thoracic Soc 12(6):821–830
cell development by a commensal bacterium of the intestinal mi- 58. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, Mcdonough JE,
crobiota. Proc Natl Acad Sci U S A 107(27):12204–12209 Gosselink JV, Cooper J, Sin DD, Mohn WW, Hogg JC (2012)
40. Scher JU, Abramson SB (2011) The microbiome and rheumatoid The lung tissue microbiome in chronic obstructive pulmonary dis-
arthritis. Nat Rev Rheumatol 7(10):569–578 ease. Am J Respiratory Critical Care Medicine 185(10):1073-1080
41. Abu-Shanab A, Quigley EM (2010) The role of the gut microbiota 59. Zachariah R, Spielmann MP, Harries AD, Gomani P, Graham SM,
in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol Bakali E, Humblet P (2003) Passive versus active tuberculosis case
7(12):691–701 finding and isoniazid preventive therapy among household contacts
42. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, in a rural district of Malawi. Int J Tuberculosis Lung Disease 7(11):
Semenkovich CF, Gordon JI (2004) The gut microbiota as an 1033–1039
Eur J Clin Microbiol Infect Dis

60. Piters WAADS, Sanders EAM, Bogaert D (2015) The role of the chemoresistance to colorectal cancer by modulating autophagy.
local microbial ecosystem in respiratory health and disease. Philos Cell 170(3):548–563
Trans R Soc Lond 370(1675) 74. Routy B, Le CE, Derosa L, Cpm D, Alou MT, Daillère R, Fluckiger
61. Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD (2013) A, Messaoudene M, Rauber C, Roberti MP (2018) Gut microbiome
Asthma-associated differences in microbial composition of induced influences efficacy of PD-1-based immunotherapy against epitheli-
sputum. J Allergy Clinical Immunology 131(2):1–3 al tumors. Science 359(6371):91–97
62. Garcianuñez M, Millares L, Pomares X, Ferrari R, Pérezbrocal V, 75. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC,
Gallego M, Espasa M, Moya A, Monsó E (2014) Severity-related Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC (2018)
changes of bronchial microbiome in chronic obstructive pulmonary Gut microbiome modulates response to anti-PD-1 immunotherapy
disease. J Clin Microbiol 52(12):4217–4223 in melanoma patients. Science 359(6371):97–103
63. Wu D, Hou C, Li Y, Zhao Z, Liu J, Lu X, Shang X, Xin Y (2014) 76. Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML,
Analysis of the bacterial community in chronic obstructive pulmo- Luke JJ, Gajewski TF (2018) The commensal microbiome is asso-
nary disease sputum samples by denaturing gradient gel electropho- ciated with anti-PD-1 efficacy in metastatic melanoma patients.
resis and real-time PCR. Bmc Pulmonary Medicine 14(1):179 Science 359(6371):104–108
64. Han MK, Zhou Y, Murray S, Tayob N, Noth I, Lama VN, Moore 77. Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S,
BB, White ES, Flaherty KR, Huffnagle GB (2014) Lung Tharavichitkul E, Lorvidhaya V (2010) Randomized controlled
microbiome and disease progression in idiopathic pulmonary fibro- trial of live lactobacillus acidophilus plus bifidobacterium bifidum
sis: an analysis of the COMET study. Lancet Respiratory Medicine in prophylaxis of diarrhea during radiotherapy in cervical cancer
2(7):548–556 patients. Radiat Oncol 5(1):31
65. Dickson RP, ErbDownward JR, Huffnagle GB (2014) Towards an
78. Ciorba MA, Hallemeier CL, Stenson WF, Parikh PJ (2015)
ecology of the lung: new conceptual models of pulmonary micro-
Probiotics to prevent gastrointestinal toxicity from cancer therapy:
biology and pneumonia pathogenesis. Lancet Respir Med 2(3):
an interpretive review and call to action. Current Opinion
238–246
Supportive Palliative Care 9(2):157–162
66. Smith SB, Ravel J (2017) The vaginal microbiota, host defence and
reproductive physiology. Journal of Physiology 595 (2):451-463 79. Blijlevens N, Donnelly JP, Pauw BD (2000) Mucosal barrier injury:
67. Si J, You HJ, Yu J, Sung J, Ko G (2017) Prevotella as a hub for biology, pathology, clinical counterparts and consequences of in-
vaginal microbiota under the influence of host genetics and their tensive treatment for haematological malignancy: an overview.
association with obesity. Cell Host & Microbe 21(1):97–105 Bone Marrow Transplant 25(12):1269–1278
68. Digiulio DB, Callahan BJ, Mcmurdie PJ, Costello EK, Lyell DJ, 80. Montassier E, Gastinne T, Vangay P, Alghalith GA, Bruley dVS,
Robaczewska A, Sun CL, Goltsman DS, Wong RJ, Shaw G (2015) Massart S, Moreau P, Potel G, Mf DLC, Batard E (2015)
Temporal and spatial variation of the human microbiota during Chemotherapy-driven dysbiosis in the intestinal microbiome.
pregnancy. Proc Natl Acad Sci U S A 112(35):11060 Aliment Pharmacol Ther 42(5):515–528
69. Bogaert D, Keijser B, Huse S, Rossen J, Veenhoven R, Gils EV, 81. Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D,
Bruin J, Montijn R, Bonten M, Sanders E (2011) Variability and Enot DP, Pfirschke C, Engblom C, Pittet MJ (2013) The intestinal
diversity of nasopharyngeal microbiota in children: a metagenomic microbiota modulates the anticancer immune effects of cyclophos-
analysis. PLoS One 6(2):e17035 phamide. Science 342(6161):971–976
70. Yan M, Pamp SJ, Fukuyama J, Hwang PH, Cho DY, Holmes S, 82. Crawford PA, Gordon JI (2005) Microbial regulation of intestinal
Relman DA (2013) Nasal microenvironments and interspecific in- radiosensitivity. Proc Natl Acad Sci U S A 102(37):13254–13259
teractions influence nasal microbiota complexity and S. aureus car- 83. Ciorba MA, Riehl TE, Rao MS, Clara M, Xueping E, Nava GM,
riage. Cell Host Microbe 14(6):631–640 Walker MR, Marinshaw JM, Stappenbeck TS, Stenson WF (2012)
71. Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, Tang L, Zhao Lactobacillus probiotic protects intestinal epithelium from radiation
H, Stenvang J, Li Y (2017) Metagenomic analysis of faecal injury in a TLR-2/cyclo-oxygenase-2-dependent manner.
microbiome as a tool towards targeted non-invasive biomarkers Gastroenterology 140(6):829–838
for colorectal cancer. Gut 66(1):70–78 84. Wang A, Ling Z, Yang Z, Kiela PR, Wang T, Wang C, Cao L, Geng
72. Touchefeu Y, Montassier E, Nieman K, Gastinne T, Potel G, de F, Shen M, Ran X (2015) Gut microbial dysbiosis may predict
Bruley VS, Vacon FL, La Cochetière MF (2014) Systematic re- diarrhea and fatigue in patients undergoing pelvic cancer radiother-
view: the role of the gut microbiota in chemotherapy- or apy: a pilot study. PLoS One 10(5):e0126312
radiation-induced gastrointestinal mucositis-current evidence and 85. LloydPrice J, Mahurkar A, Rahnavard G, Crabtree J, Orvis J, Hall
potential clinical applications. Alimentary Pharmacology A, Brady A, Creasy H, McCracken C, Giglio M (2017) Strains,
Therapeutics 40(5):409–421 functions and dynamics in the expanded Human Microbiome
73. Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Project. Nature 550(7674):61–66
Nagarsheth N (2017) Fusobacterium nucleatum promotes

You might also like